More on OCGN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Ocugen (NQ:OCGN)
Delayed: 0.78 -0.03 (3.7%)
Prev. Close $0.81  
Open$0.84 
52 Wk High$ 
52 Wk Low$ 
Day High$0.84 
Day Low$0.78 
P/E N/A  
EPS$ 
Volume5,145,783 


Oct 15, 2026 08:01 AM Form 8-K Ocugen, Inc. For: Oct 15
Oct 15, 2026 06:18 AM Form 8-K Ocugen, Inc. For: Oct 13
Oct 14, 2026 06:30 AM Ocugen licenses OCU400 gene therapy to Roots Pharma for MENA region
Oct 14, 2026 06:30 AM Ocugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa
Oct 13, 2026 09:07 PM Form 4 Ocugen, Inc. For: Oct 09 Filed by: Musunuri Shankar
Oct 9, 2026 06:16 PM Form 144 Ocugen, Inc. Filed by: Musunuri Shankar
Oct 7, 2026 02:38 PM Hemostemix Announces Full LARTA Approval, Manufacturing Progress and Financing Update
Oct 6, 2026 07:03 AM Ocugen names Jolanda Crombach to lead European affiliate in Amsterdam
Oct 6, 2026 07:02 AM Ocugen Appoints Industry Executive Jolanda Crombach General Manager of European Affiliate
Oct 6, 2026 06:01 AM Form 8-K Ocugen, Inc. For: Oct 05
View All Articles

Entities mentioned with OCGN

View All Entities